ERBB2 and breast cancer: Third, even though cases with trastuzumab treatment and controls were well matched, non-mitochondrial and mitochondrial respiration in PBMCs at baseline were significantly higher in patients with HER2-negative breast cancer, compared to those with HER2-positive breast cancer.